Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Ministry Under Fire From Critics Delays Chemo Cutbacks

This article was originally published in PharmAsia News

Executive Summary

Australia is postponing for two months plans to cut the national budget by $30 million a year by changing the way it covers chemotherapy for private cancer patients. The change, which involves limiting government payment only to the exact dose of a chemotherapy drug, was to take effect in July, but because of harsh criticism that the change could jeopardize patient treatment, the Health Ministry has delayed the effective date. The change was intended to reduce alleged wastage of intravenous chemotherapy drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel